Clinical benefit rate trang 1 tải miễn phí từ tailieunhanh

"Clinical benefit rate" trang 1 - tải miễn phí từ tailieunhanh

Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: Activity and safety results from a phase II study

Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: Activity and safety results from a phase II study

10 43 1

Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy

Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy

8 74 1

Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: Results from the ERIBEX retrospective, international, multicenter study

Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: Results from the ERIBEX retrospective, international, multicenter study

9 46 1